Cargando…
COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress
SIMPLE SUMMARY: We herein report a review of the current literature on adult patients with acute leukemia (AL) infected with SARS-CoV-2. SARS-CoV-2-associated mortality ranges from 20–52% in adult patients with AL, and patients with acute myeloid leukemia have a particularly high COVID-19-related mo...
Autores principales: | Modemann, Franziska, Ghandili, Susanne, Schmiedel, Stefan, Weisel, Katja, Bokemeyer, Carsten, Fiedler, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367547/ https://www.ncbi.nlm.nih.gov/pubmed/35954374 http://dx.doi.org/10.3390/cancers14153711 |
Ejemplares similares
-
A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies
por: Ghandili, Susanne, et al.
Publicado: (2021) -
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
por: Ghandili, Susanne, et al.
Publicado: (2020) -
Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis
por: Modemann, Franziska, et al.
Publicado: (2022) -
Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment
por: Ghandili, Susanne, et al.
Publicado: (2022) -
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia
por: Wellbrock, Jasmin, et al.
Publicado: (2021)